7.2 C
Madrid
Wednesday, December 18, 2024

The Gambia to Pre-test Medicines Imported from Other Countries, Including India

The Gambian authorities will test samples of each batch of products in the shipment

Must read

Raju Vernekar
Raju Vernekar
Raju Vermekar is a senior Mumbai-based journalist who have worked with many daily newspapers. Raju contributes on versatile topics.

INDIA. Mumbai: The Gambia, a West African country, has decided to Pre-test the medicines imported from other countries, including India, to address issues related to substandard and falsified medicines entering the country.

Markieu Jannesh Kaira, Executive Director, Medicines Control Agency (MCA), Gambia, has informed Dr. Rajeev Singh Raghuvanshi, Drugs Controller General of India (DCGI), in a letter dated June 15, that the Gambia has introduced the regulation of pre-shipment document verification, physical inspection, quality control testing, and the issuance of a Clean Report of Inspection and Analysis (CRIA) for pharmaceuticals to address issues related to substandard and falsified medicines entering the country.

- Advertisement -

The regulation will be implemented on July 1. All shipments arriving into the Gambia with a bill of Lading (LADING) dated on or after July 1 will be required to produce a CRAI for Customs clearance at the Port of Entry in the Gambia.

The samples of each batch of all products in the shipment shall be withdrawn by the sample inspector for the purpose of analytical testing to be carried out at the MCA-approved laboratory.

- Advertisement -

The CRAI certificate will be valid for 90 days from the date of issuance. As such, the drug exporters should ensure proper testing of medicines before shipment, Kaira stated in his letter.

In view of Kaira’s letter, the DCGI, in a communication dated June 20, informed the drug exporters from all Indian states and Union Territories that the Gambia regulation requires all pharmaceutical products to be inspected and sampled for testing to ensure conformity to qualifying standards prior to shipment from India.

- Advertisement -

Cough syrup 

In another development, DCGI has advised the manufacturers and exporters of cough syrup from Maharashtra not to submit samples of cough syrup for testing at the Central Drugs Testing Laboratory (CDTL) in Mumbai till all pending samples get analysed. At present, the CDTL in Mumbai has the highest number of pending samples.

The number of samples of cough syrup pending in different laboratories across the country is: CDTL Mumbai, Mumbai Central, 89; IPC Gaziabad, Uttar Pradesh, 50; Regional Drugs Testing Laboratory, Chandigarh, 14; Food & Drug Laboratory, Vadodara, Gujarat, 06; and Combined Food & Drug Testing Laboratory, Jammu, Patoli Mangotrian Jammu, 06.

Also Read: Mumbai Share Broker Arrested in Connection with Illegal “Dabba” Trading

Author

  • Raju Vernekar

    Raju Vermekar is a senior Mumbai-based journalist who have worked with many daily newspapers. Raju contributes on versatile topics.

    View all posts
- Advertisement -

Archives

spot_img

Trending Today